Skip to contentB
Bio-Rad Laboratories, Inc.
B
BIOBio-Rad Laboratories, Inc. Q2 2014 · 10-Q
Revenue$536.80M$536.80M+2.2% vs Q2 2013 Net Income$31.60M$31.60M−8.7% vs Q2 2013 EPS Diluted$1.09$1.09−9.2% vs Q2 2013 Gross Profit$297,200,000−1.0% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bio-Rad Laboratories, Inc. · CIK 12208 · Engraved from SEC EDGAR
Operating Cash Flowderived$76,872,000+289.5% Free Cash Flowderived$45,943,000N/M Margins · derivedGross margin55.4%−1.8 pt vs Q2 2013
Operating margin8.5%−1.6 pt vs Q2 2013
Net margin5.9%−0.7 pt vs Q2 2013
ended Jun 30, 2014 · filed Aug 6, 2014 · 37 d after period end